{
    "id": 24059,
    "fullName": "TOP1 R364K",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TOP1 R364K does not lie within any known functional domains of the Top1 protein (UniPot.org). R364K has been demonstrated to confer topoisomerase inhibitor resistance in conjunction with TOP1 G717R in culture (PMID: 27029323), but has not been biochemically characterized and therefore, its effect on Top1 protein function is unknown (PubMed, Nov 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 6215,
                    "pubMedId": 27029323,
                    "title": "Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27029323"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7150,
        "geneSymbol": "TOP1",
        "terms": [
            "TOP1",
            "TOPI"
        ]
    },
    "variant": "R364K",
    "createDate": "07/06/2016",
    "updateDate": "11/03/2019",
    "referenceTranscriptCoordinates": {
        "id": 161649,
        "transcript": "NM_003286",
        "gDna": "chr20:g.41100170_41100172delCGCinsAAG",
        "cDna": "c.1090_1092delCGCinsAAG",
        "protein": "p.R364K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7216,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colorectal cancer cells harboring both TOP1 G717R and TOP1 R364K were resistant to LMP400 in culture (PMID: 27029323).",
            "molecularProfile": {
                "id": 24786,
                "profileName": "TOP1 R364K TOP1 G717R"
            },
            "therapy": {
                "id": 3626,
                "therapyName": "LMP400",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6215,
                    "pubMedId": 27029323,
                    "title": "Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27029323"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7217,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Ellence (epirubicin) inhibited proliferation of colorectal cancer cells harboring both TOP1 G717R and TOP1 R364K in culture (PMID: 27029323).",
            "molecularProfile": {
                "id": 24786,
                "profileName": "TOP1 R364K TOP1 G717R"
            },
            "therapy": {
                "id": 1013,
                "therapyName": "Epirubicin",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6215,
                    "pubMedId": 27029323,
                    "title": "Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27029323"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7218,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Eposin (etoposide) inhibited proliferation of colorectal cancer cells harboring both TOP1 G717R and TOP1 R364K in culture (PMID: 27029323).",
            "molecularProfile": {
                "id": 24786,
                "profileName": "TOP1 R364K TOP1 G717R"
            },
            "therapy": {
                "id": 1136,
                "therapyName": "Etoposide",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6215,
                    "pubMedId": 27029323,
                    "title": "Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27029323"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7215,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colorectal cancer cells harboring both TOP1 G717R and TOP1 R364K were resistant to LMP776 in culture (PMID: 27029323).",
            "molecularProfile": {
                "id": 24786,
                "profileName": "TOP1 R364K TOP1 G717R"
            },
            "therapy": {
                "id": 4423,
                "therapyName": "LMP776",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6215,
                    "pubMedId": 27029323,
                    "title": "Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27029323"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7214,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, concurrent TOP1 G717R and TOP1 R364K were identified in colorectal cancer cells that acquired resistance to SN-38 in culture (PMID: 27029323).",
            "molecularProfile": {
                "id": 24786,
                "profileName": "TOP1 R364K TOP1 G717R"
            },
            "therapy": {
                "id": 3982,
                "therapyName": "SN-38",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6215,
                    "pubMedId": 27029323,
                    "title": "Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27029323"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24784,
            "profileName": "TOP1 R364K",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 24786,
            "profileName": "TOP1 R364K TOP1 G717R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 161649,
            "transcript": "NM_003286",
            "gDna": "chr20:g.41100170_41100172delCGCinsAAG",
            "cDna": "c.1090_1092delCGCinsAAG",
            "protein": "p.R364K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}